Eric D. Brown

25.5k total citations · 4 hit papers
215 papers, 12.2k citations indexed

About

Eric D. Brown is a scholar working on Molecular Biology, Genetics and Molecular Medicine. According to data from OpenAlex, Eric D. Brown has authored 215 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Molecular Biology, 82 papers in Genetics and 47 papers in Molecular Medicine. Recurrent topics in Eric D. Brown's work include Bacterial Genetics and Biotechnology (79 papers), Antibiotic Resistance in Bacteria (47 papers) and RNA and protein synthesis mechanisms (44 papers). Eric D. Brown is often cited by papers focused on Bacterial Genetics and Biotechnology (79 papers), Antibiotic Resistance in Bacteria (47 papers) and RNA and protein synthesis mechanisms (44 papers). Eric D. Brown collaborates with scholars based in Canada, United States and France. Eric D. Brown's co-authors include Gerard D. Wright, Maya A. Farha, Shawn French, Craig R. MacNair, Jonathan Stokes, Amit P. Bhavsar, Michael A. D’Elia, Brian K. Coombes, Lindsey A. Carfrae and Denis M. Daigle and has published in prestigious journals such as Nature, Cell and Chemical Reviews.

In The Last Decade

Eric D. Brown

207 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibacterial drug discovery in the resistance era

2016 1.7k citations Eric D. Brown, Gerard D. Wright profile →
A Deep Learning Approach to Antibiotic Discovery

2020 1.3k citations Jonathan Stokes, Craig R. MacNair et al. profile →
A Comprehensive, CRISPR-based Functional Analysis of Essential Genes in Bacteria

2016 512 citations Tomasz L. Czarny, Eric D. Brown et al. profile →
Drug repurposing for antimicrobial discovery

2019 255 citations Maya A. Farha, Eric D. Brown Nature Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Brown Canada	53	6.9k	2.5k	2.2k	1.6k	1.5k	215	12.2k
N.C.J. Strynadka Canada	69	8.5k 1.2×	3.2k 1.3×	3.3k 1.5×	1.4k 0.9×	1.9k 1.2×	219	15.5k
Anthony Maxwell United Kingdom	66	10.1k 1.5×	3.0k 1.2×	979 0.4×	2.1k 1.3×	2.0k 1.3×	208	12.9k
Suzanne Walker United States	66	9.3k 1.4×	1.4k 0.6×	3.0k 1.3×	1.7k 1.1×	3.8k 2.5×	206	13.4k
Jean‐Marie Pagès France	60	4.8k 0.7×	6.2k 2.4×	2.4k 1.1×	2.1k 1.3×	1.1k 0.7×	261	12.5k
Gurdyal S. Besra United Kingdom	97	11.8k 1.7×	1.6k 0.6×	2.0k 0.9×	1.4k 0.9×	4.6k 3.0×	516	31.4k
Daniel J. Dwyer United States	17	4.3k 0.6×	2.2k 0.9×	1.6k 0.7×	737 0.5×	481 0.3×	23	7.9k
Karl Drlica United States	60	8.2k 1.2×	5.2k 2.1×	3.0k 1.3×	3.7k 2.4×	933 0.6×	170	14.6k
John S. Blanchard United States	54	6.9k 1.0×	1.6k 0.6×	725 0.3×	912 0.6×	1.4k 0.9×	215	10.5k
Eric J. Rubin United States	71	9.1k 1.3×	2.2k 0.9×	2.8k 1.3×	630 0.4×	848 0.6×	263	18.1k
Jean van Heijenoort France	52	4.8k 0.7×	1000 0.4×	2.6k 1.2×	802 0.5×	1.6k 1.0×	175	7.9k

Countries citing papers authored by Eric D. Brown

Since Specialization

Citations

This map shows the geographic impact of Eric D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Brown more than expected).

Fields of papers citing papers by Eric D. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Brown. The network helps show where Eric D. Brown may publish in the future.

Co-authorship network of co-authors of Eric D. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Brown. A scholar is included among the top collaborators of Eric D. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Brown. Eric D. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Worrall, L.J., Tianjun Sun, Jinhong Hu, et al.. (2025). Cryo-EM analyses unveil details of mechanism and targocil-II mediated inhibition of S. aureus WTA transporter TarGH. Nature Communications. 16(1). 3224–3224. 1 indexed citations

Koteva, Kalinka, Yunjin Lee, David Sychantha, et al.. (2025). Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library. Nature Communications. 16(1). 7337–7337.

Worrall, L.J., et al.. (2024). Cryo-EM analysis of S. aureus TarL, a polymerase in wall teichoic acid biogenesis central to virulence and antibiotic resistance. Science Advances. 10(9). eadj3864–eadj3864. 2 indexed citations

Farha, Maya A., Megan M. Tu, & Eric D. Brown. (2024). Important challenges to finding new leads for new antibiotics. Current Opinion in Microbiology. 83. 102562–102562. 10 indexed citations

Carfrae, Lindsey A., Kenneth Rachwalski, Shawn French, et al.. (2023). Inhibiting fatty acid synthesis overcomes colistin resistance. Nature Microbiology. 8(6). 1026–1038. 48 indexed citations

Johnson, Jarrod W., Michael J. Ellis, Craig R. MacNair, et al.. (2022). Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery. ACS Medicinal Chemistry Letters. 13(2). 284–291. 14 indexed citations

MacNair, Craig R., Maya A. Farha, Michael H. Serrano‐Wu, et al.. (2022). Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant. ACS Infectious Diseases. 8(4). 768–777. 22 indexed citations

El-Halfawy, Omar M., Tomasz L. Czarny, Ronald S. Flannagan, et al.. (2019). Discovery of an antivirulence compound that reverses β-lactam resistance in MRSA. Nature Chemical Biology. 16(2). 143–149. 63 indexed citations

French, Shawn, Jean‐Philippe Côté, Jonathan Stokes, Ray Truant, & Eric D. Brown. (2017). Bacteria Getting into Shape: Genetic Determinants of E. coli Morphology. mBio. 8(2). 22 indexed citations

10.

Stokes, Jonathan, Shawn French, Olga G. Ovchinnikova, et al.. (2016). Cold Stress Makes Escherichia coli Susceptible to Glycopeptide Antibiotics by Altering Outer Membrane Integrity. Cell chemical biology. 23(2). 267–277. 68 indexed citations

11.

French, Shawn, Chand S. Mangat, Amrita Bharat, et al.. (2016). A robust platform for chemical genomics in bacterial systems. Molecular Biology of the Cell. 27(6). 1015–1025. 53 indexed citations

12.

Allison, Sarah E., Soumaya Zlitni, Rahul Das, et al.. (2013). Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA. Bioorganic & Medicinal Chemistry Letters. 23(8). 2426–2431. 36 indexed citations

13.

Brown, Eric D.. (2012). Will Twitter Make You a Better Investor? A Look at Sentiment, User Reputation and Their Effect on the Stock Market. Journal of the Association for Information Systems. 25(5). 920–927. 29 indexed citations

14.

Jomaa, Ahmad, Jaime Martín‐Benito, Ryszard A. Zielke, et al.. (2011). Understanding ribosome assembly: the structure of in vivo assembled immature 30S subunits revealed by cryo-electron microscopy. RNA. 17(4). 697–709. 46 indexed citations

15.

Farha, Maya A., et al.. (2010). Chemical Genomic Approaches to Study Model Microbes. Chemistry & Biology. 17(6). 624–632. 14 indexed citations

16.

Falconer, Shannon B. & Eric D. Brown. (2009). New screens and targets in antibacterial drug discovery. Current Opinion in Microbiology. 12(5). 497–504. 47 indexed citations

17.

Daigle, Denis M., Stanislas Mayer, Debasis Mallik, et al.. (2006). A 2.13 Å Structure of E. coli Dihydrofolate Reductase Bound to a Novel Competitive Inhibitor Reveals a New Binding Surface Involving the M20 Loop Region. Journal of Medicinal Chemistry. 49(24). 6977–6986. 45 indexed citations

18.

D’Elia, Michael A., Mark P. Pereira, Wenjun Zhao, et al.. (2006). Lesions in Teichoic Acid Biosynthesis in Staphylococcus aureus Lead to a Lethal Gain of Function in the Otherwise Dispensable Pathway. Journal of Bacteriology. 188(12). 4183–4189. 161 indexed citations

19.

Bhavsar, Amit P., et al.. (2004). Teichoic Acid Is an Essential Polymer in Bacillus subtilis That Is Functionally Distinct from Teichuronic Acid. Journal of Bacteriology. 186(23). 7865–7873. 83 indexed citations

20.

Li, Xiaoming, et al.. (2004). Multicopy Suppressors for Novel Antibacterial Compounds Reveal Targets and Drug Efflux Susceptibility. Chemistry & Biology. 11(10). 1423–1430. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact